HK1011697A1 - Monoclonal antibody active against cd44v6 - Google Patents

Monoclonal antibody active against cd44v6

Info

Publication number
HK1011697A1
HK1011697A1 HK98112912A HK98112912A HK1011697A1 HK 1011697 A1 HK1011697 A1 HK 1011697A1 HK 98112912 A HK98112912 A HK 98112912A HK 98112912 A HK98112912 A HK 98112912A HK 1011697 A1 HK1011697 A1 HK 1011697A1
Authority
HK
Hong Kong
Prior art keywords
pct
active against
monoclonal antibody
antibody active
sec
Prior art date
Application number
HK98112912A
Other languages
English (en)
Inventor
Gunther R Adolf
Erik Patzelt
Original Assignee
Boehringer Ingelheim Int
Karlsruhe Forschzent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19944431297 external-priority patent/DE4431297A1/de
Application filed by Boehringer Ingelheim Int, Karlsruhe Forschzent filed Critical Boehringer Ingelheim Int
Publication of HK1011697A1 publication Critical patent/HK1011697A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70585—CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK98112912A 1994-06-08 1998-12-07 Monoclonal antibody active against cd44v6 HK1011697A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4419913 1994-06-08
DE19944431297 DE4431297A1 (de) 1994-09-02 1994-09-02 Monoklonaler Antikörper gegen CD44v6
PCT/EP1995/002126 WO1995033771A1 (de) 1994-06-08 1995-06-02 MONOKLONALER ANTIKÖRPER GEGEN CD44v6

Publications (1)

Publication Number Publication Date
HK1011697A1 true HK1011697A1 (en) 1999-07-16

Family

ID=25937246

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112912A HK1011697A1 (en) 1994-06-08 1998-12-07 Monoclonal antibody active against cd44v6

Country Status (28)

Country Link
US (1) US5916561A (xx)
EP (1) EP0765343B1 (xx)
JP (2) JP3387929B2 (xx)
KR (2) KR100379217B1 (xx)
CN (1) CN1125083C (xx)
AT (1) ATE197592T1 (xx)
BG (1) BG64181B1 (xx)
BR (1) BR9507964A (xx)
CA (1) CA2192370A1 (xx)
CO (1) CO4410258A1 (xx)
CZ (1) CZ291274B6 (xx)
DE (1) DE59508864D1 (xx)
DK (1) DK0765343T3 (xx)
ES (1) ES2151603T3 (xx)
FI (1) FI964845A (xx)
GR (1) GR3035388T3 (xx)
HK (1) HK1011697A1 (xx)
HU (1) HU220168B (xx)
NO (1) NO317948B1 (xx)
NZ (1) NZ288224A (xx)
PL (1) PL190897B1 (xx)
PT (1) PT765343E (xx)
RO (1) RO118753B1 (xx)
RU (1) RU2204606C2 (xx)
SI (1) SI0765343T1 (xx)
SK (1) SK282649B6 (xx)
UA (1) UA58482C2 (xx)
WO (1) WO1995033771A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY24389A1 (es) * 1995-12-06 2001-10-25 Karlsruhe Forschzent Composición farmacéutica para el tratamiento de carcinoma de epitelio plano
US6440733B1 (en) * 1996-02-15 2002-08-27 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibodies recognizing antigens on the surface of endothelial cells of tumor vessel
DE19648209A1 (de) * 1996-11-21 1998-05-28 Boehringer Ingelheim Int Verfahren zur Tumorzelldepletion CD34-positiver Zellen
DE19708713C2 (de) * 1997-03-04 2002-11-28 Boehringer Ingelheim Int Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen
KR100501550B1 (ko) 1998-06-08 2005-07-18 후소 야쿠힝 고교 가부시끼가이샤 Ｌａｒ 포스파타제 서브유닛에 대한 항체
DE69939742D1 (de) * 1998-07-10 2008-11-27 Fuso Pharmaceutical Ind Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase
US8071072B2 (en) * 1999-10-08 2011-12-06 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20090004103A1 (en) * 1999-10-08 2009-01-01 Young David S F Cytotoxicity mediation of cells evidencing surface expression of CD44
US8048416B2 (en) * 1999-10-08 2011-11-01 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20080124327A1 (en) * 1999-10-08 2008-05-29 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) 1999-10-08 2011-05-24 Hoffmann-La Roche Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20030103985A1 (en) * 2001-05-18 2003-06-05 Boehringer Ingelheim International Gmbh Cytotoxic CD44 antibody immunoconjugates
US6972324B2 (en) 2001-05-18 2005-12-06 Boehringer Ingelheim Pharmaceuticals, Inc. Antibodies specific for CD44v6
SK15592003A3 (sk) * 2001-05-18 2004-06-08 Boehringer Ingelheim International Gmbh Protilátková molekula, farmaceutický prostriedok s jej obsahom a jej použitie
ES2309193T3 (es) * 2001-08-24 2008-12-16 Celecure As Nuevos inhibidores de la angiogenesis basados en el dominio de enlace al acido hialuronico del receptor cd44.
US20040126379A1 (en) * 2002-08-21 2004-07-01 Boehringer Ingelheim International Gmbh Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
WO2004024750A2 (en) * 2002-09-13 2004-03-25 Dyax Corporation Cd44-binding ligands
US20040120949A1 (en) * 2002-11-08 2004-06-24 Boehringer Ingelheim International Gmbh Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
US20060140963A1 (en) * 2003-04-14 2006-06-29 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of CD59
EP1806365A1 (en) 2006-01-05 2007-07-11 Boehringer Ingelheim International GmbH Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
EP2266593A1 (en) * 2009-06-24 2010-12-29 Karlsruher Institut für Technologie Use of CD44v6 in the treatment of ophthalmic diseases
EP2467401B1 (en) * 2009-08-19 2017-01-18 Merck Patent GmbH Antibodies for the detection of integrin complexes in ffpe material
CN102337298B (zh) * 2011-08-19 2013-11-06 黄开红 一种输送siRNA的免疫纳米载体及其制备方法和应用
PL2886126T3 (pl) 2013-12-23 2017-11-30 Exchange Imaging Technologies Gmbh Nanocząstka sprzężona z peptydami wiążącymi CD44
KR20210004961A (ko) * 2018-02-22 2021-01-13 아브마트 상하이 컴퍼니, 엘티디. 치료 항체 및 그의 용도
CN109593125A (zh) * 2018-12-12 2019-04-09 深圳市龙华区人民医院 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p1及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012631A1 (en) * 1992-11-20 1994-06-09 Isis Innovation Limited Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors
ATE159953T1 (de) * 1993-06-18 1997-11-15 Biotie Therapies Oy Zusammensetzungen und diagnostische verfahren unter verwendung von monoklonalen antikoerpern gegen cd44v6
US6010865A (en) * 1993-06-22 2000-01-04 Boehringer Ingelheim International Gmbh Process for detecting a variant CD44 gene product

Also Published As

Publication number Publication date
DK0765343T3 (da) 2000-12-27
AU701885B2 (en) 1999-02-11
GR3035388T3 (en) 2001-05-31
PT765343E (pt) 2001-02-28
FI964845A0 (fi) 1996-12-04
KR970703368A (ko) 1997-07-03
KR100379217B1 (ko) 2003-06-11
NO317948B1 (no) 2005-01-10
PL190897B1 (pl) 2006-02-28
WO1995033771A1 (de) 1995-12-14
HU220168B (hu) 2001-11-28
SK154896A3 (en) 1997-08-06
CZ291274B6 (cs) 2003-01-15
JP3387929B2 (ja) 2003-03-17
JPH10501797A (ja) 1998-02-17
HU9603387D0 (en) 1997-01-28
RU2204606C2 (ru) 2003-05-20
CZ359196A3 (en) 1997-11-12
CN1125083C (zh) 2003-10-22
EP0765343A1 (de) 1997-04-02
JP2003034700A (ja) 2003-02-07
NZ288224A (en) 1999-04-29
ES2151603T3 (es) 2001-01-01
BG64181B1 (bg) 2004-03-31
EP0765343B1 (de) 2000-11-15
SI0765343T1 (en) 2001-02-28
DE59508864D1 (de) 2000-12-21
CO4410258A1 (es) 1997-01-09
SK282649B6 (sk) 2002-10-08
NO965239D0 (no) 1996-12-06
FI964845A (fi) 1996-12-04
ATE197592T1 (de) 2000-12-15
NO965239L (no) 1996-12-06
AU2737095A (en) 1996-01-04
CA2192370A1 (en) 1995-12-14
UA58482C2 (uk) 2003-08-15
BG101024A (en) 1997-09-30
CN1152925A (zh) 1997-06-25
BR9507964A (pt) 1997-09-02
PL317536A1 (en) 1997-04-14
US5916561A (en) 1999-06-29
HUT76260A (en) 1997-07-28
RO118753B1 (ro) 2003-10-30

Similar Documents

Publication Publication Date Title
HK1011697A1 (en) Monoclonal antibody active against cd44v6
EP1470146B8 (en) Antibodies against the muc18 antigen
EP1467757A4 (en) USE OF ANTIBODIES TO THE MUC18 ANTIGEN
ATE248605T1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
NZ301916A (en) Monoclonal antibodies to il-5 for use as antagonists to il-5 related disorders
AU7635396A (en) Treatment and diagnosis of infections due to helicobacter pylori
NZ331557A (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
ATE189122T1 (de) Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung
KR950702207A (ko) Tlp 복합체에 대한 항원성 부위와 이의 항체(antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them)
MX9606108A (es) Anticuerpos monoclonales contra cd44v6.
ATE56617T1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
ATE328088T1 (de) Transketolase-verwandtes protein
CA2308142A1 (en) Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050602